News

Intuitive Surgical (ISRG) is in focus after voluntarily recalling certain Da Vinci surgical system components tied to a potential E-brake pin issue. This development is prompting fresh attention on product risk and how it might factor into the stock. See our latest analysis for Intuitive Surgical. Against this backdrop, Intuitive Surgical’s short term share price momentum has softened, with the stock down 4.5% over the past week and 9.7% over the past 90 days. However, the 3 year total...

Intuitive Surgical, Inc. (ISRG) closed at $406.78 in the latest trading session, marking a -1.16% move from the prior day.

ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.

Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the 10 Best AI Stocks to Watch in July. On July 6, Evercore ISI lowered its target price for Intuitive Surgical Inc. (NASDAQ:ISRG) to $430 from $480 and kept an In Line rating on the stock. The firm’s Q2 preview for MedTech, Life Sciences Tools, and Diagnostics shows […]

The Japanese medical robotics company, a joint venture between Kawasaki and Sysmex, is preparing for a European launch after expanding in the Asia-Pacific region.

The options market has priced a sizable range of outcomes for the surgical robotics leader, and if you hold the shares, you are already carrying that full exposure.

Pre-Market Stock Futures: Futures are trading mixed after another tough day across Wall Street, with all the major indices crushed early on, before the Nasdaq made a late-afternoon push to wind up just modestly higher at 25,870, up 0.20%. The S&P 500 also rallied in the afternoon, erasing a big deficit, to finish the session ... Here Are Thursday’s Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, T

If you hold shares in this surgical robotics leader, you are already carrying a sizable two-sided risk, whether you trade options or not.

Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.

ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.

Generate an immediate income that you keep regardless, plus the opportunity to buy the stock cheaper should its price fall far enough.

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $432.83, signifying a +1.6% move from its prior day's close.

The company has the elements that make a fantastic long-term investment.

While investors fixate on slowing elective surgeries, a powerful, non-obvious growth engine is accelerating inside the company's U.S. business.

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Piper Sandler Companies stock has delivered a strong 5 year return, yet with the recent pullback and a mixed valuation score, the current share price around US$71.09 looks less like a straightforward bargain and more like a test of how much investors are willing to pay for its track record. Over the past 5 years the stock has returned 165.8%, which sets a high bar for future returns to justify the current valuation. Positive sentiment around Piper Sandler's research and advisory work, such...

Intuitive Surgical (NasdaqGS:ISRG) reported strong quarterly results, supported by solid procedure volumes and rapid adoption of its new da Vinci 5 system. Management issued softer guidance for future procedure growth, citing competitive pressures and increased regulatory scrutiny. The company was recently added to the Russell 1000 Dynamic Index and removed from the Russell Top 50 Index, altering its index exposure. Intuitive Surgical focuses on robotic assisted surgery, with its da Vinci...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (NASDAQ:ISRG) and its peers.

Intuitive Surgical has faced margin pressure before and bounced back.

Intuitive Surgical is approaching a pivotal earnings update as strong forecasts square off against a stock that has lost its footing.

In this month’s Mailbag, Fools write in about market caps, parenting, AI, adding to winning investments, and what can happen when decades of patient investing quietly compound into opportunities to help others.

Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Brown Advisory, an investment management company, released its “Brown Large-Cap Growth Strategy” for the first-quarter 2026 investor letter. A copy of the letter is available to download here. The Brown Advisory Large-Cap Growth Strategy experienced a decline in the first quarter of 2026, modestly trailing the Russell 1000 Growth Index. Despite negative absolute returns amidst volatility, […]

Intuitive Surgical, Inc. (NASDAQ:ISRG) has declined more than 29% over the past 6 months and is now trading close to its 52-week lows. The downward pressure stems from regulatory scrutiny regarding instrument reuse and concerns over Chinese competition. ​However, the Street expects the stock to rebound, with analysts’ 12-month average price target suggesting more than […]

Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for investors weighing portfolio strategy.

Stryker (NYSE:SYK) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results. Stryker absorbed a March 11 cyberattack and heavy restructuring charges while defending its joint replacement franchise. Intuitive posted another crisp beat on the back of da Vinci 5 adoption. Two medtech giants, two very different quarters. A Cyber ... Stryker Vs. Intuitive Surgical: Stryker’s Joint-Replacement Moat Over Intuitive’s Premium Valuation

The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance and delivering strong returns.

The company dominates the robotic surgery market.

Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.

Intuitive Surgical has been a huge winner over the long term, but there's a potential opening for new investors right now.